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Abstract: One of the main problems with current vascular stents is a lack of endothelial cell 
interactions, which if sufﬁ  cient, would create a uniform healthy endothelium masking the 
underlying foreign metal from inﬂ  ammatory cell interference. Moreover, if endothelial cells 
from the arterial wall do not adhere to the stent, the stent can become loose and dislodge. 
Therefore, the objective of this in vitro study was to design a novel biomimetic nanostructured 
coating (that does not contain drugs) on conventional vascular stent materials (speciﬁ  cally, 
titanium) for improving vascular stent applications. Rosette nanotubes (RNTs) are a new class 
of biomimetic nanotubes that self-assemble from DNA base analogs and have been shown in 
previous studies to sufﬁ  ciently coat titanium and enhance osteoblast cell functions. RNTs have 
many desirable properties for use as vascular stent coatings including spontaneous self-assembly 
in body ﬂ  uids, tailorable surface chemistry for speciﬁ  c implant applications, and nanoscale 
dimensions similar to those of the natural vascular extracellular matrix. Importantly, the results 
of this study provided the ﬁ  rst evidence that RNTs functionalized with lysine (RNT–K), even 
at low concentrations, signiﬁ  cantly increase endothelial cell density over uncoated titanium. 
Speciﬁ  cally, 0.01 mg/mL RNT–K coated titanium increased endothelial cell density by 37% 
and 52% compared to uncoated titanium after 4 h and three days, respectively. The excellent 
cytocompatibility properties of RNTs (as demonstrated here for the ﬁ  rst time for endothelial 
cells) suggest the need for the further exploration of these novel nanostructured materials for 
vascular stent applications.
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Introduction
Vascular stents are predominantly metal structures inserted into partially clogged 
arteries to promote normal blood ﬂ  ow and prevent myocardial infarctions. There is 
an enormous market for vascular stents with $918 million in US sales in 2005 alone.1 
The constant contact of vascular stents with blood has been the source of several unre-
solved efﬁ  cacy issues.2,3 For example, conventional bare metal stents often trigger an 
inﬂ  ammatory response leading to scar tissue formation, known as restenosis, which 
constricts blood ﬂ  ow defeating the original purpose of the stent.2 Drug-eluting stents 
counteract such events by releasing immunosuppressants, however, these immuno-
suppressants can also suppress desirable endothelial cell growth and sometimes lead 
to late-stage thrombosis.3 For the above reasons, this study focused on the design, 
synthesis, and investigation of a new non-drug containing material called rosette 
nanotubes (RNTs) to coat titanium stent surfaces in order to enhance endothelial cell 
adhesion and proliferation.
RNTs are novel materials composed of DNA base analogs featuring the hydrogen 
bonding arrays of both guanine and cytosine, the G^C motif. This module self-
assembles spontaneously in aqueous solutions ﬁ  rst into a rosette supermacrocycle International Journal of Nanomedicine 2009:4 92
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maintained by 18 hydrogen bonds (Figures 1A–B). Then 
the rosettes undergo self-organization via noncovalent 
stacking interactions to form helical nanotubes with an inner 
diameter of 11 Å and lengths ranging from a few nanome-
ters to several micrometers (Figure 1C). Such nanometer 
dimensions of RNTs mimic the dimensions of the natural 
components of tissues, such as collagen ﬁ  brils. Furthermore, 
the outside of the tubes can be functionalized to possess 
various peptides and amino acid side chains (eg, K, RGD 
[arginine–glycine–aspartic acid]) to interact with cells and 
stimulate speciﬁ  c tissue growth.
For orthopedic applications, previous studies have 
shown that various functionalized RNTs have attractive 
properties including remarkably improved osteoblast 
(bone-forming cell) functions when coated on traditional 
implant materials (such as titanium) or embedded in 
hydrogels.4–8 Promoted osteoblast functions have been 
attributed to the nanoscale biologically-inspired features 
and the rich lysine or peptide moieties of RNTs. In addition, 
RNTs have been investigated as novel injectable materials 
which solidify when heated to body temperatures.4–7 Of 
course as with any new nanotechnology-derived material, 
toxicity could be a concern. However, in a recent in vivo 
study, Journeay and colleagues reported that RNTs did 
not trigger severe inﬂ  ammatory responses and had low 
pulmonary toxicity in vivo at mg/mL concentrations (toxic 
concentrations above which RNTs have been shown to 
promote cell functions).9
For all of the above reasons, especially due to the promise 
of coating titanium with RNTs for orthopedic applications, 
this report focuses on endothelial cell functions on RNT-
coated titanium with the aim of improving vascular stent 
performance.
Materials and methods
Substrate preparation and characterization
Titanium squares (Ti, 10 × 10 × 0.5 mm, Alfa Aesar titanium 
foil, 99% metal basis) and glass coverslips (Fisher Scien-
tiﬁ  c, Pittsburgh, PA) were cleaned in acetone for 15 min, 
sonicated for 15 min, and rinsed three times with Millipore 
distilled/deionized water (ddH2O; Millipore, Billerica, MA). 
They were then soaked, sonicated, and rinsed in 70% ethanol 
then in ddH2O. The glass was etched (1 M NaOH, 1 h) and 
thoroughly rinsed in ddH2O. The substrates were then placed 
in a drying oven overnight and autoclaved before the cell 
adhesion experiments.
The RNT–K (RNTs functionalized with lysine) were 
synthesized as previously reported,10 and the corresponding 
solutions were sterilized by ﬁ  ltration via a 0.22 μm syringe 
ﬁ  lter.4 To conﬁ  rm the formation of the RNTs, a sample 
(0.01 mg/mL) was imaged on a Philips, EM410 PW6008 
transmission electron microscope (Philips, Amsterdam, The 
Netherlands). One day prior to seeding cells, the titanium 
substrate samples were placed in solutions of either 0.01 mg/
mL or 0.001 mg/mL RNT–K for 45 min, then removed and 
left to dry overnight.
Endothelial cell culture
Rat aortic endothelial cells (RAEC; VEC Technologies, 
Rensselaer, NY) were cultured in MCDB–131 Complete 
medium (VEC Technologies) under standard cell culture 
conditions (37 °C, humidiﬁ  ed, 5% CO2/95% air). Medium 
was replaced every other day.
Endothelial cell adhesion experiment
For the 4 h cell adhesion studies, a 12-well plate was 
prepared with three samples consisting of 0.01 mg/mL 
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Figure 1 Schematic illustration of the self–assembly process of RNTs with a lysine (K) side chain (RNT–K) when placed in body ﬂ  uids.  A) The guanine–cytosine (G^C) motif 
with a lysine side chain; B) a rosette supermacrocycle self–assembled from six G^C motifs maintained by 18 H-bonds; and C) the rosettes stack up to form a stable nanotube 
with a ∼3.5 nm outer and a 11 Å inner tube diameter.International Journal of Nanomedicine 2009:4 93
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RNT-coated titanium, 0.001 mg/mL RNT-coated titanium, 
uncoated titanium, and a glass reference. Cells were seeded 
onto the substrates at a density of 3500 cells/cm2 in 2 mL of 
MCDB-131 Complete Medium (Sigma-Aldrich, St. Louis, 
MO) and were incubated for 4 h. The medium was then 
removed and the substrates were rinsed with phosphate-
buffered saline (PBS; 3×) to remove non-adherent cells. 
The adherent cells were then ﬁ  xed with 10% formalin 
(Fisher Scientiﬁ  c) for 10 min and then rinsed with PBS 
(3×). The cells were then ﬁ  xed with 0.1% Triton X–100 
(Sigma-Aldrich) for 5 min. After sequential PBS rinsing, 
endothelial cells were stained with rhodamine–phalliodin 
(Molecular Probes, Carlsbad, CA) for 20 min, rinsed with 
PBS (2 ×), stained with DAPI (Invitrogen, Carlsbad, CA) for 
5 min and rinsed with PBS. 4',6-Diamidino-2-phenylindole 
(DAPI) was chosen as a ﬂ  uorescent dye since it stains the cell 
nucleus and can be used to count the number of cells pres-
ent on opaque substrates. Rhodamine phalliodin was also 
chosen because it stains the F-actin ﬁ  laments of endothelial 
cells and, thus, highlights cell morphology. After staining, 
endothelial cells were observed using a Zeiss Axiovert 
200 M ﬂ  uorescence microscope (Carl Zeiss Microimaging 
Inc., Thornwood, NY) and ﬁ  ve different areas of each sample 
were imaged. The cell density was determined by counting 
cells using Image Pro Analyzer (Media Cybernetics, Inc., 
Bethesda, MD).
Endothelial cell proliferation experiment
For the proliferation studies, three sets of substrates were 
seeded with endothelial cells at a density of 1000 cells/cm2 
and were placed in an incubator for 1, 3, and 5 days. The 
medium was changed every other day. After each time period, 
cells were stained and counted as described above.
Statistical analysis
All cellular experiments were run in triplicate and repeated 
at least three different times for each substrate. Numerical 
data were analyzed with a Student’s t–test to make pair-
wise comparisons. Statistical signiﬁ  cance was considered 
at p  0.1.
Results and discussion
RNT–K morphology
Transmission electron microscopy images showed that the 
RNT–K used in the present study formed a dense network 
of long nanotubes each ∼3.5 nm in diameter and several 
hundred nanometers in length (Figure 2), consistent with 
earlier reports.4
Enhanced endothelial cell adhesion
The 4 h adhesion study provided the ﬁ  rst evidence that 
endothelial cells adhered at a higher density to RNT-coated 
titanium compared to uncoated titanium substrates. Spe-
ciﬁ  cally, the 0.01 mg/mL and 0.001 mg/mL RNT–K-coated 
titanium increased endothelial cell density by 37% and 22%, 
respectively, over uncoated titanium (Figures 3 and 4).
One hypothesis concerning why increased endothelial 
cell adhesion was observed on RNT-coated compared to 
uncoated titanium is that the biomimetic features of the nano-
structured RNTs favored endothelial adhesion whereas the 
uncoated titanium did not possess such biologically-inspired 
surface roughness. In addition, another study reported that 
poly-L-lysine-coated vascular stents signiﬁ  cantly improved 
endothelial cell adhesion compared to uncoated controls 
perhaps due to the electrostatic or optimal initial protein 
interactions between poly-L-lysine and endothelial cells.11 
Considering the rich lysine side chains and well controlled 
nanometer spatial distributions of such lysine side chains on 
RNTs, the surface chemistry of titanium was altered through 
RNT coatings to possibly promote greater endothelial cell 
attachment and spreading as shown in Figure 5.
Endothelial cell proliferation
Endothelial cell density increased on all substrates after 
5 days of culture (Figure 6). More importantly, results of this 
Figure 2 Transmission electron micrograph of RNT–K (0.01 mg/mL in water).   Arrows 
point to the RNTs.
Abbreviation: RNT–K, rosette nanotube–lysine side chain.International Journal of Nanomedicine 2009:4 94
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Figure 3 Enhanced endothelial cell adhesion on 0.01 and 0.001 mg/mL RNT–K coated on titanium after 4 h compared to uncoated titanium.
Notes: Data are mean values ± SEM; N = 3. *p  0.05; **p  0.1 when compared to uncoated titanium; and #p  0.005 when compared to all other substrates.
Abbreviations: RNT–K, rosette nanotube–lysine side chain; SEM, standard error of mean.
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Figure 4 Fluorescence microscopy images of increased endothelial cell densities after 4 h on A) 0.01 mg/mL RNT–K coated on titanium and B) 0.001 mg/mL RNT–K coated on 
titanium compared to C) uncoated titanium. Dots in the images represent DAPI-stained endothelial cell nuclei. Scale bars = 50 μm (left), 40 μm (middle), and 50 μm (right).
Abbreviations: DAPI, 4´,6-diamidino-2-phenylindole; RNT–K, rosette nanotube–lysine side chain.
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study provided the ﬁ  rst evidence that RNT–K-coated tita-
nium greatly improved endothelial cell functions compared 
to uncoated titanium (Figure 6). Speciﬁ  cally, the 0.01 mg/
mL and 0.001 mg/mL RNT-coated titanium increased endo-
thelial cell density 52% and 21%, respectively, compared 
to uncoated titanium after three days of culture. In addi-
tion, endothelial cell densities were signiﬁ  cantly higher on 
0.01 mg/mL RNT–K coated titanium than on 0.001 mg/mL 
RNT–K-coated titanium after three days of culture. Such 
data supports the positive role that higher concentrations of 
RNTs can play in promoting endothelial cell coverage of 
vascular stents by (a) presenting more lysine side chains per 
unit of surface area, and/or by (b) more closely resembling 
the natural nanostructure of vascular tissue when coated 
on titanium.
By day 5, the RNT-coated titanium still had a higher 
average endothelial cell density, but the differences were 
no longer statistically signiﬁ  cant (Figure 6). However, 
when analyzing endothelial cell numbers from day 1 to 5, 
it was clear that endothelial cells reached conﬂ  uency faster 
on the RNT-coated titanium than on the uncoated titanium. 
Furthermore, Figures 7 and 8 illustrate the difference 
in endothelial cell conﬂ  uency on titanium when coated 
with RNTs.
In short, this study demonstrated for the first time 
improved endothelial cell density on RNT-coated titanium International Journal of Nanomedicine 2009:4 95
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Figure 5 Fluorescence microscopy images of endothelial cells spreading on 0.01 mg/mL and 0.001 mg/mL RNT–K coated on titanium and uncoated titanium after 4 h. F-actin 
ﬁ  laments were stained with rhodamine phalliodin.
Abbreviation: RNT–K, rosette nanotube–lysine side chain.
0.01 mg/mL RNT–K 0.001 mg/mL RNT–K Uncoated titanium
50 μm 50 μm 50 μm
Figure 6 Enhanced endothelial cell density on RNT–K coated on titanium after 3 and 5 days. 
Notes: Data are mean values ± SEM; N = 3; #p  0.01 and ##p  0.05 compared to uncoated titanium on day 3; *p  0.05 compared to 0.001 mg/mL RNT–K coated on 
titanium on day 3; **p  0.001 compared to respective substrates on day 1; and ***p  0.001 compared to respective substrates on day 3.
Abbreviations: RNT–K, rosette nanotube–lysine side chain; SEM, standard error of mean.
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compared to uncoated titanium controls. Importantly, this 
was achieved without embedding or coating drugs on the 
titanium stent surface, rather, such positive data was obtained 
after simply soaking titanium in RNT-containing solutions 
for 45 min. This study, thus, suggests the potential of using 
biomimetic RNTs as a quickly applied, efﬁ  cient coating on 
titanium to improve cytocompatibility properties for vascular 
stent applications.
Conclusions
In summary, this initial investigation concerning endothe-
lial cell functions on RNT-coated titanium stents yielded International Journal of Nanomedicine 2009:4 96
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0.01 mg/mL RNT–K 0.001 mg/mL RNT–K Uncoated titanium
Day 1
Day 3
Day 5
Figure 7 Fluorescence microscopy images of increased endothelial cell densities (DAPI stain) on 0.01 mg/mL and 0.001 mg/mL RNT–K coated on titanium compared to 
uncoated titanium after 1, 3, and 5 days of culture.
Abbreviations: DAPI, 4´,6-diamidino-2-phenylindole; RNT–K, rosette nanotube-lysine side chain.
0.01 mg/mL RNT–K 0.001 mg/mL RNT–K Uncoated titanium
Day 1
Day 3
Day 5
Figure 8 Fluorescence microscopy images of double-stained endothelial cells on 0.01 mg/mL and 0.001 mg/mL RNT–K coated on titanium and uncoated titanium after 1, 3, 
and 5 days of culture. F-actin ﬁ  laments were stained by rhodamine phalliodin and cell nuclei were stained by DAPI.
Abbreviations: DAPI, 4´,6-diamidino-2-phenylindole; RNT–K, rosette nanotube–lysine side chain.International Journal of Nanomedicine 2009:4 97
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very positive results. Titanium coated with RNTs showed a 
signiﬁ  cant concentration effect of increased endothelial cell 
density compared to uncoated titanium after 4 h and after 
three days. While further investigation is clearly needed, such 
as using dynamic ﬂ  ow rather than the static tests conducted 
here, the results of this study provided promise for the use 
of RNTs to improve vascular stent applications.
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